PriceTargets.com logo

RenaissanceRe - RNR Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $284.50
  • Forecasted Upside: 5.82%
  • Number of Analysts: 16
  • Breakdown:
  • 1 Sell Ratings
  • 11 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$268.86 As of 12/4/2025 04:59 PM ET
▲ +2.448 (0.92%)

This chart shows the closing price for RNR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New RenaissanceRe Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RNR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RNR

Analyst Price Target is $284.50
▲ +5.82% Upside Potential
This price target is based on 16 analysts offering 12 month price targets for RenaissanceRe in the last 3 months. The average price target is $284.50, with a high forecast of $426.00 and a low forecast of $238.00. The average price target represents a 5.82% upside from the last price of $268.86.

This chart shows the closing price for RNR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 16 polled investment analysts is to hold stock in RenaissanceRe. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 1 sell ratings
Ratings as of
6/12/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 1 sell ratings
Ratings as of
9/10/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 5 hold ratings
  • 1 sell ratings
Ratings as of
12/9/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 2 sell ratings
Ratings as of
3/9/2025
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 2 sell ratings
Ratings as of
6/7/2025
  • 0 strong buy ratings
  • 4 buy ratings
  • 7 hold ratings
  • 1 sell ratings
Ratings as of
9/5/2025
  • 0 strong buy ratings
  • 4 buy ratings
  • 11 hold ratings
  • 1 sell ratings
Ratings as of
11/4/2025
  • 0 strong buy ratings
  • 4 buy ratings
  • 11 hold ratings
  • 1 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 11 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/1/2025Weiss RatingsReiterated RatingBuy (B) ➝ Buy (B)
11/25/2025Weiss RatingsReiterated RatingBuy (B) ➝ Buy (B)
11/17/2025Morgan StanleyBoost TargetOverweight ➝ Overweight$280.00 ➝ $290.00
10/31/2025Weiss RatingsReiterated RatingBuy (B-) ➝ Buy (B-)
10/30/2025Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$278.00 ➝ $285.00
10/14/2025The Goldman Sachs GroupInitiated CoverageSell$256.00
10/14/2025The Goldman Sachs GroupInitiated CoverageSell$256.00
10/9/2025JPMorgan Chase & Co.Reiterated RatingOverweight ➝ Neutral$303.00
10/8/2025UBS GroupBoost TargetNeutral ➝ Neutral$265.00 ➝ $272.00
10/8/2025BarclaysSet Target$278.00
10/8/2025Weiss RatingsReiterated RatingBuy (B) ➝ Buy (B)
10/8/2025Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$269.00 ➝ $278.00
10/7/2025CowenReiterated RatingHold ➝ Hold
10/1/2025Evercore ISISet TargetUnderperform ➝ In-Line$244.00
10/1/2025Evercore ISIUpgradeStrong Sell ➝ Hold
9/27/2025Weiss RatingsReiterated RatingBuy (B) ➝ Buy (B)
9/15/2025Wolfe ResearchInitiated CoveragePeer Perform
8/13/2025Cantor FitzgeraldUpgradeHold
8/13/2025CitigroupInitiated CoverageBuy$288.00
8/12/2025Cantor FitzgeraldInitiated CoverageNeutral$238.00
7/28/2025UBS GroupBoost TargetNeutral ➝ Neutral$250.00 ➝ $265.00
7/28/2025Keefe, Bruyette & WoodsBoost TargetMarket Perform ➝ Market Perform$268.00 ➝ $269.00
7/24/2025BarclaysBoost TargetEqual Weight ➝ Equal Weight$256.00 ➝ $273.00
7/14/2025Morgan StanleyLower TargetOverweight ➝ Overweight$285.00 ➝ $280.00
7/10/2025Wells Fargo & CompanyReiterated RatingOverweight ➝ Equal Weight$267.00 ➝ $269.00
7/9/2025Keefe, Bruyette & WoodsReiterated RatingOutperform ➝ Market Perform$282.00 ➝ $268.00
7/7/2025BarclaysUpgradeUnderweight ➝ Equal Weight$231.00 ➝ $256.00
5/19/2025Morgan StanleySet TargetOverweight ➝ Overweight$275.00 ➝ $285.00
4/29/2025Keefe, Bruyette & WoodsBoost TargetOutperform ➝ Outperform$279.00 ➝ $282.00
4/25/2025Morgan StanleyUpgradeEqual Weight ➝ Overweight$235.00 ➝ $275.00
4/24/2025JMP SecuritiesReiterated RatingMarket Perform ➝ Market Perform
4/11/2025BarclaysLower TargetUnderweight ➝ Underweight$234.00 ➝ $231.00
4/11/2025Jefferies Financial GroupLower TargetHold ➝ Hold$266.00 ➝ $265.00
4/10/2025Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$277.00 ➝ $271.00
4/8/2025JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$284.00 ➝ $284.00
3/26/2025Bank of AmericaLower TargetBuy ➝ Buy$437.00 ➝ $426.00
2/4/2025Keefe, Bruyette & WoodsLower TargetOutperform ➝ Outperform$318.00 ➝ $294.00
1/31/2025Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$265.00 ➝ $245.00
1/30/2025JMP SecuritiesReiterated RatingMarket Perform ➝ Market Perform
1/30/2025Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$288.00 ➝ $277.00
1/14/2025Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$301.00 ➝ $288.00
1/10/2025Keefe, Bruyette & WoodsBoost TargetOutperform ➝ Outperform$310.00 ➝ $318.00
1/6/2025BarclaysDowngradeEqual Weight ➝ Underweight$284.00 ➝ $234.00
1/3/2025JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$280.00 ➝ $284.00
12/18/2024Jefferies Financial GroupReiterated RatingBuy ➝ Hold$304.00 ➝ $282.00
11/12/2024Keefe, Bruyette & WoodsLower TargetOutperform ➝ Outperform$316.00 ➝ $310.00
11/7/2024JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$274.00 ➝ $280.00
11/7/2024Evercore ISIBoost TargetUnderperform ➝ Underperform$229.00 ➝ $246.00
10/10/2024JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$267.00 ➝ $274.00
10/10/2024Bank of AmericaBoost TargetBuy ➝ Buy$364.00 ➝ $391.00
10/10/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$280.00 ➝ $314.00
10/9/2024Jefferies Financial GroupBoost TargetBuy ➝ Buy$270.00 ➝ $314.00
10/9/2024Evercore ISIBoost TargetUnderperform ➝ Underperform$218.00 ➝ $229.00
9/10/2024CitigroupBoost TargetBuy ➝ Buy$262.00 ➝ $298.00
9/4/2024BarclaysInitiated CoverageEqual Weight$287.00
7/26/2024Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$288.00 ➝ $280.00
7/25/2024JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$265.00 ➝ $267.00
7/11/2024Bank of AmericaBoost TargetBuy ➝ Buy$334.00 ➝ $347.00
7/11/2024JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$245.00 ➝ $265.00
7/10/2024Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$257.00 ➝ $240.00
7/9/2024UBS GroupLower TargetNeutral ➝ Neutral$251.00 ➝ $248.00
5/1/2024JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$237.00 ➝ $245.00
5/1/2024Evercore ISIBoost TargetUnderperform ➝ Underperform$216.00 ➝ $218.00
4/11/2024Evercore ISIBoost TargetUnderperform ➝ Underperform$213.00 ➝ $216.00
4/8/2024JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$204.00 ➝ $237.00
2/5/2024UBS GroupBoost TargetNeutral ➝ Neutral$229.00 ➝ $238.00
2/5/2024BMO Capital MarketsBoost TargetOutperform ➝ Outperform$216.00 ➝ $295.00
1/10/2024TD CowenInitiated CoverageMarket Perform
12/14/2023Evercore ISIInitiated CoverageUnderperform$200.00
11/22/2023CitigroupInitiated CoverageBuy$251.00
10/11/2023Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$229.00 ➝ $240.00
10/6/2023Jefferies Financial GroupLower Target$249.00 ➝ $246.00
9/8/2023The Goldman Sachs GroupInitiated CoverageBuy$242.00
8/21/2023Bank of AmericaLower TargetBuy ➝ Buy$275.00 ➝ $266.00
7/11/2023BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$198.00 ➝ $216.00
6/20/2023Morgan StanleyInitiated CoverageEqual Weight$222.00
5/25/2023Jefferies Financial GroupUpgradeHold ➝ Buy$234.00 ➝ $238.00
4/10/2023Jefferies Financial GroupBoost TargetHold$215.00 ➝ $221.00
4/5/2023Wells Fargo & CompanyBoost TargetOverweight$245.00 ➝ $256.00
3/31/2023JPMorgan Chase & Co.Boost TargetUnderweight$170.00 ➝ $175.00
2/2/2023Wells Fargo & CompanyBoost TargetOverweight$234.00 ➝ $245.00
1/19/2023BMO Capital MarketsInitiated CoverageMarket Perform$187.00
1/18/2023Wells Fargo & CompanyBoost TargetOverweight$200.00 ➝ $234.00
11/29/2022Wells Fargo & CompanyBoost TargetOverweight$184.00 ➝ $200.00
11/22/2022Morgan StanleyBoost TargetEqual Weight$150.00 ➝ $195.00
11/3/2022Wells Fargo & CompanyBoost Target$171.00 ➝ $184.00
10/12/2022Wells Fargo & CompanyBoost TargetOverweight$169.00 ➝ $171.00
8/19/2022Morgan StanleyLower TargetEqual Weight$162.00 ➝ $150.00
7/12/2022Jefferies Financial GroupDowngradeBuy ➝ Hold$173.00 ➝ $162.00
5/23/2022Morgan StanleyLower TargetEqual Weight$175.00 ➝ $162.00
2/23/2022Morgan StanleyBoost TargetEqual Weight$172.00 ➝ $175.00
11/19/2021Morgan StanleyBoost TargetEqual Weight$158.00 ➝ $172.00
11/18/2021Jefferies Financial GroupInitiated CoverageBuy$192.00
11/8/2021Bank of AmericaUpgradeNeutral ➝ Buy$163.00 ➝ $218.00
10/29/2021Morgan StanleyLower TargetEqual Weight$166.00 ➝ $158.00
10/15/2021Morgan StanleyLower TargetEqual Weight$182.00 ➝ $166.00
8/16/2021Morgan StanleyBoost TargetEqual Weight$179.00 ➝ $182.00
4/16/2021Morgan StanleyLower TargetEqual Weight$195.00 ➝ $191.00
3/24/2021Morgan StanleyBoost TargetEqual Weight$194.00 ➝ $195.00
1/29/2021Morgan StanleyLower TargetEqual Weight$199.00 ➝ $194.00
1/28/2021Wells Fargo & CompanyLower TargetOverweight$229.00 ➝ $220.00
1/12/2021Morgan StanleyBoost TargetEqual Weight$196.00 ➝ $199.00
1/8/2021The Goldman Sachs GroupUpgradeNeutral ➝ Buy$194.00 ➝ $199.00
1/4/2021JPMorgan Chase & Co.Boost TargetUnderweight$160.00 ➝ $162.00
(Data available from 12/4/2020 forward)

News Sentiment Rating

1.44 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 52 very positive mentions
  • 14 positive mentions
  • 8 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2025
  • 40 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/7/2025
  • 21 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2025
  • 32 very positive mentions
  • 26 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/6/2025
  • 45 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/5/2025
  • 24 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2025
  • 30 very positive mentions
  • 28 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2025
  • 41 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2025

Current Sentiment

  • 41 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

RenaissanceRe logo
RenaissanceRe Holdings Ltd., together with its subsidiaries, provides reinsurance and insurance products in the United States and internationally. The company operates through Property, and Casualty and Specialty segments. The Property segment writes property catastrophe excess of loss reinsurance and excess of loss reinsurance to insure insurance and reinsurance companies against natural and man-made catastrophes, including hurricanes, earthquakes, typhoons, and tsunamis, as well as winter storms, freezes, floods, fires, windstorms, tornadoes, explosions, and acts of terrorism; and other property class of products, such as proportional reinsurance, property per risk, property reinsurance, binding facilities, and regional U.S. multi-line reinsurance. The Casualty and Specialty segment writes various classes of products, such as directors and officers, medical malpractice, and professional indemnity; automobile and employer's liability, casualty clash, umbrella or excess casualty, workers' compensation, and general liability; financial and mortgage guaranty, political risk, surety, and trade credit; and accident and health, agriculture, aviation, cyber, energy, marine, satellite, and terrorism. It distributes products and services primarily through intermediaries. The company invests in and manages funds. RenaissanceRe Holdings Ltd. was founded in 1993 and is headquartered in Pembroke, Bermuda.
Read More

Today's Range

Now: $268.86
Low: $265.00
High: $269.86

50 Day Range

MA: $258.16
Low: $231.75
High: $269.04

52 Week Range

Now: $268.86
Low: $219.00
High: $290.78

Volume

376,849 shs

Average Volume

385,141 shs

Market Capitalization

$12.40 billion

P/E Ratio

7.47

Dividend Yield

0.60%

Beta

0.26

Frequently Asked Questions

What sell-side analysts currently cover shares of RenaissanceRe?

The following Wall Street sell-side analysts have issued research reports on RenaissanceRe in the last twelve months: Bank of America Corporation, Barclays PLC, Cantor Fitzgerald, Citigroup Inc., Cowen Inc, Evercore ISI, Jefferies Financial Group Inc., JMP Securities, JPMorgan Chase & Co., Keefe, Bruyette & Woods, Morgan Stanley, The Goldman Sachs Group, Inc., UBS Group AG, Weiss Ratings, Wells Fargo & Company, and Wolfe Research.
View the latest analyst ratings for RNR.

What is the current price target for RenaissanceRe?

0 Wall Street analysts have set twelve-month price targets for RenaissanceRe in the last year. Their average twelve-month price target is $284.50, suggesting a possible upside of 5.8%. Bank of America Corporation has the highest price target set, predicting RNR will reach $426.00 in the next twelve months. Cantor Fitzgerald has the lowest price target set, forecasting a price of $238.00 for RenaissanceRe in the next year.
View the latest price targets for RNR.

What is the current consensus analyst rating for RenaissanceRe?

RenaissanceRe currently has 1 sell rating, 11 hold ratings and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in RNR, but not buy more shares or sell existing shares.
View the latest ratings for RNR.

What other companies compete with RenaissanceRe?

Other companies that are similar to RenaissanceRe include Arch Capital Group, Axis Capital, Everest Group, Progressive and Reinsurance Group of America. Learn More about companies similar to RenaissanceRe.

How do I contact RenaissanceRe's investor relations team?

RenaissanceRe's physical mailing address is RENAISSANCE HOUSE 12 CROW LANE, PEMBROKE D0, HM 19. The insurance provider's listed phone number is (441) 295-4513 and its investor relations email address is [email protected]. The official website for RenaissanceRe is www.renre.com. Learn More about contacing RenaissanceRe investor relations.